UNSPSC 51111810: Testolactone

This classification denotes a steroidal aromatase inhibitor with the molecular formula C19H24O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6J9BLA949Q, chemically known as d-homo-17a-oxaandrosta-1,4-diene-3,17-dione but generally known as testolactone, which bears US NIH Compound Identifier 5407. European Medicines Agency schedules Testolactone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10936MIG. The term TESTOLACTONE is an International Non-Proprietary Name.

UNSPSC 51111810 Testolactone is a Commodity code covering the procurement of testolactone, a synthetic steroidal compound used primarily in pharmaceutical and medical applications. State and local governments procure this substance for use in public health programs, correctional facilities, and state-operated medical institutions where testolactone may be administered as part of clinical treatment protocols. The code captures purchases of the active pharmaceutical ingredient or finished pharmaceutical products containing testolactone, typically through health department procurement offices, state pharmacy benefit programs, or facility-level medical supply contracts managed by corrections, mental health, or general healthcare agencies.

The source provides no recent state or local contract opportunities tagged to UNSPSC 51111810. Without posted RFP, RFQ, IFB, or ITB notices, geographic distribution cannot be characterized and no representative solicitations can be named. Testolactone is a specialized pharmaceutical with limited modern clinical use, and procurement activity under this code appears minimal or concentrated among a narrow set of issuing bodies; publicly posted opportunities may not be available for this particular substance.